Cite
HARVARD Citation
Venkataraman, V. et al. (2021). Secondary histiocytic sarcoma with BRAFV600E mutation responsive to MAPK‐targeted therapy presenting with recurrence with mTOR mutation responsive to mTOR‐targeted therapy. Pediatric blood & cancer. 68 (10), p. n/a. [Online].